Vivos Therapeutics Revenue and Competitors

Toronto, ON CAN

Location

N/A

Total Funding

Health

Industry

Estimated Revenue & Valuation

  • Vivos Therapeutics's estimated annual revenue is currently $37M per year.(i)
  • Vivos Therapeutics's estimated revenue per employee is $270,000

Employee Data

  • Vivos Therapeutics has 137 Employees.(i)
  • Vivos Therapeutics grew their employee count by 10% last year.

Vivos Therapeutics's People

NameTitleEmail/Phone
1
Sr. VPReveal Email/Phone
2
Sr. VPReveal Email/Phone
3
Sr. VPReveal Email/Phone
4
Sr. VP, Capital MarketsReveal Email/Phone
5
CEOReveal Email/Phone
6
VP, SalesReveal Email/Phone
7
AI Enhancement LeaderReveal Email/Phone
8
Product and Systems ManagerReveal Email/Phone
9
Medical Billing Support SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.5M303%N/AN/A
#2
$110.4M327-9%N/AN/A
#3
$55.8M18844%N/AN/A
#4
$114.1M338-11%N/AN/A
#5
$57.6M1948%N/AN/A
#6
$35.9M133-3%N/AN/A
#7
$29.4M109-14%N/AN/A
#8
$0.8M60%N/AN/A
#9
$708.4M18747%N/AN/A
#10
$1.1M8-47%N/AN/A
Add Company

What Is Vivos Therapeutics?

Headquartered in Denver Colorado, Vivos Therapeutics Inc. is a research and development company that provides training for dentist and health care providers, allowing them to integrate breathing wellness into their practice. The Vivos System is a proprietary, non-invasive, non-surgical treatment protocol, administered by a multidisciplinary team of highly-trained health care professionals. This revolutionary technology represents the first hope for a lasting solution to the problem of sleep apnea. Vivos Therapeutics has over 765 Certified Provides in 21 States and two Canadian Provinces. Vivos Therapeutics is proven to deliver an effective and non-invasive, non-surgical solution for sleep apnea, a serious disorder which can result from an obstructed airway caused by narrow dental arches and/or an underdeveloped jaw. The Vivos System consists of multi-disciplinary therapeutic protocols and oral appliances which increase and enhance the airway. It is the only non-surgical treatment to offer a potentially permanent solution for sleep apnea.

keywords:N/A

N/A

Total Funding

137

Number of Employees

$37M

Revenue (est)

10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vivos Therapeutics News

2022-04-06 - National Asset Management Inc. Purchases 28283 Shares of ...

owned 0.34% of Vivos Therapeutics worth $179,000 as of its most recent filing with the Securities and Exchange Commission. A number of other...

2022-03-30 - Vivos Therapeutics Schedules Fourth Quarter and Full Year ...

HIGHLANDS RANCH, Colo., March 31, 2022 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company'') (NASDAQ: VVOS),...

2022-03-30 - Vivos Therapeutics Reports Fourth Quarter and Full Year ...

Vivos Therapeutics Inc. (NASDAQ: VVOS) is a medical technology company focused on developing and commercializing a suite of innovative...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14M1371%N/A
#2
$28.8M13734%N/A
#3
$28.1M137-53%N/A
#4
$28.8M1374%N/A
#5
$16.4M1375%N/A